Skip to main content
. 2022 May 13;12:883798. doi: 10.3389/fcimb.2022.883798

Table 5.

Recurrence and persistence 28 ± 3 days after medications.

Clindamycin Group (n=41) FuRong Group (n=39) P value
Relapse
 AV 6 10 0.22
 BV 5 9 0.20
Persist
 AV 4 1 0.18
 BV 5 2 0.26